ArticleInternational journal of women's health2026
From Local Evidence to Regional Leadership: Post-Preeclampsia Care in Thailand.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypertensive disorders of pregnancy, particularly preeclampsia, identify women at increased risk of persistent hypertension and later cardiovascular disease, yet postpartum services often remain organized around short-term obstetric recovery. Thailand is well positioned to address this discontinuity because prospective local studies have demonstrated elevated blood pressure, hypertension, and selected cardiovascular and renal risk markers at 6 weeks and 6-12 months after preeclampsia or gestational hypertension. The principal policy gap is therefore not the absence of warning evidence, but the lack of a standardized and auditable handover from maternity services to primary care and cardiovascular prevention. This commentary was informed by a targeted, non-systematic examination of peer-reviewed studies, international professional recommendations, World Health Organization resources, and publicly accessible national guidance available in English through June 2026. Evidence was selected to characterize longer-term cardiovascular and renal risk following hypertensive disorders of pregnancy, summarize relevant Thai postpartum findings, and identify regional health-system approaches that could inform continuity of care in Thailand. Vietnam, Malaysia, and Mongolia were purposively selected as complementary examples of community noncommunicable-disease integration, local-clinic follow-up after hypertensive pregnancy, and continuity of care across geographic distance, respectively. We propose a standardized multicenter pilot comprising documented risk communication and a named receiving provider before discharge; blood-pressure evaluation within 72 hours for women with severe hypertension and no later than 7-10 days for other women with hypertensive disorders; structured assessment at 6-12 weeks and 6-12 months; permanent recording of hypertensive pregnancy history; and annual cardiovascular-risk review. National scale-up should follow evaluation of feasibility, completion, equity, and clinical outcomes. The aim is not to create a parallel specialty service, but to convert an established obstetric warning sign into accountable long-term cardiovascular and renal prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.